Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

被引:26
作者
Wu, Feitong [1 ,2 ,3 ]
Juonala, Markus [4 ,5 ]
Jacobs Jr, David R. [6 ]
Daniels, Stephen R. [7 ]
Kahonen, Mika [8 ,9 ]
Woo, Jessica G. [10 ,11 ]
Sinaiko, Alan R. [12 ]
Viikari, Jorma S. A. [4 ,5 ]
Bazzano, Lydia A. [13 ]
Burns, Trudy L. [14 ]
Steinberger, Julia [15 ]
Urbina, Elaine M. [11 ,16 ]
Venn, Alison J. [1 ]
Raitakari, Olli T. [17 ,18 ,19 ,20 ,21 ]
Dwyer, Terence [1 ,22 ,23 ]
Magnussen, Costan G. [1 ,2 ,17 ,18 ,19 ]
机构
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Univ Melbourne, Fac Med Dent & Hlth Sci, Baker Dept Cardiometabol Hlth, Melbourne, Vic, Australia
[4] Univ Turku, Dept Med, Turku, Finland
[5] Turku Univ Hosp, Div Med, Turku, Finland
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[7] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland
[10] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
[11] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[12] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[13] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[14] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[15] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA
[16] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[17] Univ Turku, Ctr Populat Hlth Res, Turku, Finland
[18] Turku Univ Hosp, Turku, Finland
[19] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[20] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland
[21] Univ Turku, InFLAMES Res Flagship, Turku, Finland
[22] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England
[23] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会; 芬兰科学院; 美国国家卫生研究院; 欧洲研究理事会;
关键词
atherosclerosis; epidemiology; lipoproteins; longitudinal studies; risk assessment; risk factors; HEART-FAILURE; UNITED-STATES; EXERCISE; ADHERENCE; RISK; INTERVENTION; GUIDELINES; CHILDREN; OUTCOMES; UTILITY;
D O I
10.1161/CIRCULATIONAHA.123.064296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary cholesterol target in clinical practice in children and adults, non-high-density lipoprotein cholesterol (non-HDL- C) has been suggested as a more accurate measure of atherosclerotic cardiovascular disease (ASCVD) risk. We examined the associations of childhood non-HDL-C and LDL- C levels with adult ASCVD events and determined whether non-HDL- C has better utility than LDL-C in predicting adult ASCVD events. METHODS: This prospective cohort study included 21 126 participants from the i3C Consortium (International Childhood Cardiovascular Cohorts). Proportional hazards regressions were used to estimate the risk for incident fatal and fatal/nonfatal ASCVD events associated with childhood non-HDL- C and LDL-C levels (age- and sex-specific z scores; concordant/discordant categories defined by guideline-recommended cutoffs), adjusted for sex, Black race, cohort, age at and calendar year of child measurement, body mass index, and systolic blood pressure. Predictive utility was determined by the C index. RESULTS: After an average follow-up of 35 years, 153 fatal ASCVD events occurred in 21 126 participants (mean age at childhood visits, 11.9 years), and 352 fatal/nonfatal ASCVD events occurred in a subset of 11 296 participants who could be evaluated for this outcome. Childhood non-HDL-C and LDL-C levels were each associated with higher risk of fatal and fatal/nonfatal ASCVD events (hazard ratio ranged from 1.27 [95% CI, 1.14-1.41] to 1.35 [95% CI, 1.13-1.60] per unit increase in the risk factor z score). Non-HDL-C had better discriminative utility than LDL-C (difference in C index, 0.0054 [95% CI, 0.0006-0.0102] and 0.0038 [95% CI, 0.0008-0.0068] for fatal and fatal/nonfatal events, respectively). The discordant group with elevated non-HDL-C and normal LDL-C had a higher risk of ASCVD events compared with the concordant group with normal non-HDL- C and LDL-C (fatal events: hazard ratio, 1.90 [95% CI, 0.98-3.70]; fatal/nonfatal events: hazard ratio, 1.94 [95% CI, 1.23-3.06]). CONCLUSIONS: Childhood non-HDL-C and LDL-C levels are associated with ASCVD events in midlife. Non-HDL-C is better than LDL-C in predicting adult ASCVD events, particularly among individuals who had normal LDL-C but elevated non-HDL-C. These findings suggest that both non-HDL-C and LDL-C are useful in identifying children at higher risk of ASCVD events, but non-HDL-C may provide added prognostic information when it is discordantly higher than the corresponding LDL-C and has the practical advantage of being determined without a fasting sample.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 50 条
[1]   Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease [J].
Vega, Gloria Lena ;
Grundy, Scott M. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) :563-567
[2]   Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment [J].
Yun, Yeo-Min .
ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) :221-222
[3]   Determinants of Achieved LDL Cholesterol and "Non-HDL" Cholesterol in the Management of Dyslipidemias [J].
Packard, Chris J. .
CURRENT CARDIOLOGY REPORTS, 2018, 20 (08)
[4]   Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias [J].
Chris J. Packard .
Current Cardiology Reports, 2018, 20
[5]   Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation [J].
Johannesen, Camilla Ditlev Lindhardt ;
Mortensen, Martin Bodtker ;
Nordestgaard, Borge Gronne ;
Langsted, Anne .
ATHEROSCLEROSIS, 2025, 403
[6]   Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study [J].
Hansen, Malene Kaerslund ;
Mortensen, Martin Bodtker ;
Olesen, Kevin Kris Warnakula ;
Thrane, Pernille Gro ;
Maeng, Michael .
LANCET REGIONAL HEALTH-EUROPE, 2024, 36
[7]   Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment [J].
Carr, Stuart S. ;
Hooper, Amanda J. ;
Sullivan, David R. ;
Burnett, John R. .
PATHOLOGY, 2019, 51 (02) :148-154
[8]   Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood [J].
Shoar, Saeed ;
Ikram, Waleed ;
Shah, Ahmed Ali ;
Farooq, Najam ;
Gouni, Srikanth ;
Khavandi, Soheila ;
Tabibzadeh, Elsa ;
Khavandi, Siamak .
REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (02) :295-299
[9]   Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort [J].
Carbayo Herencia, Julio A. ;
Simarro Rueda, Marta ;
Palazon Bru, Antonio ;
Molina Escribano, Francisca ;
Ponce Garcia, Isabel ;
Artigao Rodenas, Luis Miguel ;
Caldevilla Bernardo, David ;
Divison Garrote, Juan A. ;
Gil Guillen, Vicente Francisco .
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2018, 30 (02) :64-71
[10]   Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].
Boekholdt, S. Matthijs ;
Arsenault, Benoit J. ;
Mora, Samia ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Nestel, Paul J. ;
Simes, R. John ;
Durrington, Paul ;
Hitman, Graham A. ;
Welch, K. M. A. ;
DeMicco, David A. ;
Zwinderman, Aeilko H. ;
Clearfield, Michael B. ;
Downs, John R. ;
Tonkin, Andrew M. ;
Colhoun, Helen M. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Kastelein, John J. P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309